| J9271 | Injection, pembrolizumab, 1 mg | 6,800 | $40 | $285.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 870 | $90 | $76.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 830 | $60 | $51.3K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 40 | $1,070 | $42.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 330 | $90 | $31K |
| J0897 | Injection, denosumab, 1 mg | 1,320 | $20 | $23.8K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,890 | $1 | $21.8K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 340 | $60 | $20.1K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,450 | $10 | $14.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,420 | $10 | $14.2K |